Petros Pharmaceuticals: Invitation to the Q3 Virtual Investor Summit

New Jersey and Pennsylvania--(Newsfile Corp. - August 11, 2021) - Petros Pharmaceuticals (NASDAQ: PTPI) today announced that Fady Boctor, President, Chief Commercial Officer will be attending the Q3 Virtual Investor Summit.

About Petros Pharmaceuticals

Petros Pharmaceuticals aims to be a premier Mens health therapeutics company, prescription and over-the-counter (OTC), with a currently commercialized multi-product asset portfolio and a pre-clinical asset in development for the potential treatment of Peyronies disease.

For further information:

Petros Pharmaceuticals
Fady Boctor
2153706927
[email protected]

About the Investor Summit

The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 80+ companies and over 800 investors, consisting of institutional investors, family offices, and private wealth.

To request complimentary investor registration: please click here: Complimentary Investor Registration.

Contact:

Sasha Murray at [email protected]

You May Also Be Interested In

• Voghion Accelerates Its European Market Strategy with an Upgraded Seller Growth Program
• ITC Makes Affirmative Final Determination in Landmark Trade Case on Hardwood and Decorative Plywood from China, Indonesia, and Vietnam, Wiley Reports
• Century Communities Announces Grand Opening of New Home Phase at Uplands in Puyallup, Washington